Overexpressed Skp2 within 5p amplification detected by array-based comparative genomic hybridization in associated with poor prognosis of glioblastomas

Cancer Science

Volumn 96, Issue 10, 2005, Pages 676-683

  Saigusa, Kuniyasu ^a,b   Hashimoto, Naoya ^c   Tsuda, Hitoshi ^d   Yokoi, Sana ^a,b   Maruno, Motohiko ^c   Yoshimine, Toshiki ^c   Aoyagi, Masaru ^a   Ohno, Kikuo ^a   Imoto, Issei ^a,b   Inazawa, Johji ^a,b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

S PHASE KINASE ASSOCIATED PROTEIN 2;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; CHROMOSOME 10P; CHROMOSOME 10Q; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 14Q; CHROMOSOME 18Q; CHROMOSOME 22Q; CHROMOSOME 3Q; CHROMOSOME 5P; CHROMOSOME 9P; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CORRELATION ANALYSIS; DNA SCREENING; GENE AMPLIFICATION; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCUS; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ANALYSIS; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SURVIVAL RATE;

BRAIN NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 5; DNA, NEOPLASM; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION PROFILING; GLIOBLASTOMA; HUMANS; NUCLEIC ACID HYBRIDIZATION; PROGNOSIS; S-PHASE KINASE-ASSOCIATED PROTEINS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 28444478038     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2005.00099.x     Document Type: Article

References (39)

1. Ohgaki H, Dessen P, Jourde, B et al. Genetic pathways to glioblastoma: a population-based study. Cancer Res 2004; 64: 6892-9.
2. Kleihues P, Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro-oncology 1999; 1: 44-51.
3. Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993; 9: 138-41.
4. Wong AJ, Bigner SH, Bigner DD et al. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 1987; 84: 6899-903.
5. Fleming TP, Sexena A, Clark WC et al. Amplification and/or over-expression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res 1992; 52: 4550-3.
6. Reifenberger G, Ichimura K, Reifenberger J et al. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. Cancer Res 1996; 56: 5141-5.
7. Ichimura K, Bolin MB, Goike HM et al. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. Cancer Res 2000; 60: 417-24.
8. Nakamura M, Yonekawa Y, Kleihues P et al. Promoter hypermethylation of the RB1 gene in glioblastomas. Lab Invest 2001; 81: 77-82.
9. Steck PA, Pershouse MA, Jasser SA et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997; 15: 356-62.
10. Wang SI, Puc J, Li J et al. Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 1997; 57: 4183-6.
11. Smith JS, Tachibana I, Passe SM et al. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J Natl Cancer Inst 2001; 93: 1246-56.
12. Inazawa J, Inoue J, Imoto I. Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes. Cancer Sci 2004; 95: 559-63.
13. Sonoda I, Imoto I, Inoue J et al. Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous-cell carcinoma. Cancer Res 2004; 64: 3741-7.
14. Takada H, Imoto I, Tsuda H et al. Screening of DNA copy-number aberrations in gastric cancer cell lines by array-based comparative genomic hybridization. Cancer Sci 2005; 96: 100-10.
15. Izumi H, Inoue J, Yokoi S et al. Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in non-small cell lung cancers. Hum Mol Genet 2005; 14: 997-1007.
16. Hirose Y, Aldape KD, Chang S et al. Grade II astrocytomas are subgrouped by chromosome aberrations. Cancer Genet Cytogenet 2003; 142: 1-7.
17. Cowell JK, Matsui S, Wang YD et al. Application of bacterial artificial chromosome array-based comparative genomic hybridization and spectral karyotyping to the analysis of glioblastoma multiforme. Cancer Genet Cytogenet 2004; 151: 36-51.
18. Yokoi S, Yasui K, Saito-Ohara F et al. A novel target gene, SKP2, within the 5p13 amplicon that is frequently detected in small cell lung cancers. Am J Pathol 2002; 161: 207-16.
19. Yokoi S, Yasui K, Mori M et al. Amplification and overexpression of SKP2 are associated with metastasis of non-small-cell lung cancers to lymph nodes. Am J Pathol 2004; 165: 175-80.
20. Sanada T, Yokoi S, Arii S et al. Skp2 overexpression is a p27Kip1-independent predictor of poor prognosis in patients with biliary tract cancers. Cancer Sci 2004; 95: 969-76.
21. Ariyama Y, Sakabe T, Shinomiya T et al. Identification of amplified DNA sequences on double minute chromosomes in a leukemic cell line KY821 by means of spectral karyotyping and comparative genomic hybridization. J Hum Genet 1998; 43: 187-90.
22. Imoto I, Yang ZQ, Pimkhaokham A et al. Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas. Cancer Res 2001; 61: 6629-34.
23. Koschny R, Koschny T, Froster UG et al. Comparative genomic hybridization in glioma: a meta-analysis of 509 cases. Cancer Genet Cytogenet 2002; 135: 147-59.
24. Suzuki T, Maruno M, Wada K et al. Genetic analysis of human glioblastomas using a genomic microarray system. Brain Tumor Pathol 2004; 21: 27-34.
25. Knuutila S, Bjorkqvist AM, Autio, K et al. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 1998; 152: 1107-23.
26. Gstaiger M, Jordan R, Lim M et al. Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci USA 2001; 98: 5043-8.
27. Kudo Y, Kitajima S, Sato S et al. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res 2001; 61: 7044-7.
28. Masuda TA, Inoue H, Sonoda H et al. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis. Cancer Res 2002; 62: 3819-25.
29. Chiarle R, Fan Y, Piva R et al. S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase. Am J Pathol 2002; 160: 1457-66.
30. Hui AM, Cui X, Makuuchi M et al. Decreased p27 (Kip1) expression and cyclin D1 overexpression, alone and in combination, influence recurrence and survival of patients with resectable extrahepatic bile duct carcinoma. Hepatology 1999; 30: 1167-73.
31. Hui AM, Li X, Shi YZ et al. p27(Kip1) expression in normal epithelia, precancerous lesions, and carcinomas of the gallbladder: association with cancer progression and prognosis. Hepatology 2000; 31: 1068-72.
32. Wirbelauer C, Sutterluty H, Blondel M et al. The F-box protein Skp2 is a ubiquitylation target of a Cul1-based core ubiquitin ligase complex: evidence for a role of Cul1 in the suppression of Skp2 expression in quiescent fibroblasts. EMBO J 2000; 19: 5362-75.
33. Imaki H, Nakayama K, Delehouzee S et al. Cell cycle-dependent regulation of the Skp2 promoter by GA-binding protein. Cancer Res 2003; 63: 4607-13.
34. Shigemasa K, Gu L, O'Brien TJ et al. Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma. Clin Cancer Res 2003; 9: 1756-63.
35. Mamillapalli R, Gavrilova N, Mihaylova VT et al. PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27 (KIP1) through the ubiquitin E3 ligase SCF (SKP2). Curr Biol 2001; 11: 263-7.
36. Raffel C, Frederick L, O'Fallon JR et al. Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations. Clin Cancer Res 1999; 5: 4085-90.
37. Backlund LM, Nilsson BR, Goike HM et al. Short postoperative survival for glioblastoma patients with a dysfunctional Rb1 pathway in combination with no wild-type PTEN. Clin Cancer Res 2003; 9: 4151-8.
38. Lee SH, McCormick F. Downregulation of Skp2 and p27/Kip1 synergistically induces apoptosis in T98G glioblastoma cells. J Mol Med 2005; 83: 296-307.
39. Mitchell BS. The proteasome: an emerging therapeutic target in cancer. N Engl J Med 2003; 348: 2597-8.